William F. Peacock, MD, provides an overview of opioid induced constipation and reviews the current treatment landscape and management strategies.
Expert Insight Into the Efficacy and Economic Burden of Opioid Induced Constipation Treatments
Dr William F. Peacock reviews key highlights and clinical implications from the post hoc analysis of a single dose of methylnaltrexone in patients suffering from opioid-induced constipation.
An expert in emergency medicine comments on the adverse event profile and concomitant use considerations with the administration of methylnaltrexone in patients suffering from opioid-induced constipation.
Dr William F. Peacock provides insight on the economic burden of opioid-induced constipation management strategies, highlighting the impact of hospitalization rates and prescription costs.
William F. Peacock, MD, discusses real-world implications with opioid-induced constipation and comments on unmet needs in treating patients.
An expert in emergency medicine shares his thoughts on the patient population inclusion criteria study designs when investigating treatment efficacy in patients with opioid-induced constipation.
Dr William F. Peacock shares clinical pearls for the management of opioid-induced constipation.